Compounds > miltefosine

miltefosine and bortezomib

miltefosine has been researched along with bortezomib in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ballard, J; Be, C; Berman, A; Biggart, A; Bursulaya, B; Caridha, D; Chen, YL; Chianelli, D; Davis, LC; Eggimann, FK; Gao, MY; Gibney, M; Glynne, RJ; Groessl, T; Hein, A; Jiricek, J; Johnson, K; Khare, S; Kreishman-Deitrick, M; Lai, YH; Lerario, I; Liang, F; Liu, X; Luneau, A; Mathison, CJN; Molteni, V; Nagle, A; Pybus, B; Rao, SPS; Richmond, W; Rudewicz, PJ; Sciotti, RJ; Shapiro, M; Smith, J; Spraggon, G; Srinivas, H; Supek, F; Thompson, C; Tuntland, T; Wiesmann, C; Xie, Y; Yeh, V1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

3 other study(ies) available for miltefosine and bortezomib

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases.
    Journal of medicinal chemistry, 2020, 10-08, Volume: 63, Issue:19

    Topics: Animals; Antiprotozoal Agents; Dogs; Humans; Leishmania donovani; Leishmania major; Leishmaniasis, Visceral; Liver; Macaca fascicularis; Mice; Mice, Inbred BALB C; Oxazoles; Proteasome Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Triazoles

2020
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023